Details for Patent: 3,830,827
Summary for Patent: 3,830,827
| Title: | L-alpha-hydrazino-alpha-substituted-beta-(3,4-dihydroxyphenyl)propionic acid substantially free of the d isomer,the lower alkyl esters thereof,and the pharmaceutically acceptable salts thereof,wherein the substituent is lower alkyl |
| Abstract: | A NOVEL COMPOUND IS USED TO INHIBIT MAMMALIAN DECARBOXYLASE, THE COMPOUND BEING SELECTED FROM THE GROUP CONSISTING OF L-A-HYDRAZINO-A-SUBSTITUTED -B- (3,4-DIHYDROXYPHENYL)PROPIONIC ACID SUBSTANTIALLY FREE OF THE D ISOMER, THE LOWER ALKYL ESTERS THEREOF, AND THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, WHEREIN THE SUBSTITUENT IS LOWER ALKYL. COMPOUNDS, COMPOSITIONS AND METHOD OF TREATMENT ARE INCLUDED. |
| Inventor(s): | S Karady, Sletzinger Meyer, M Ly, S Pines |
| Assignee: | Merck and Co Inc |
| Application Number: | US00287147A |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 3,830,827
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 3,830,827
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 192578 | ⤷ Start Trial | |||
| Argentina | 193037 | ⤷ Start Trial | |||
| Argentina | 205428 | ⤷ Start Trial | |||
| Austria | 318573 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
